Research ArticleConference Proceedings

Pulmonary Rehabilitation: Mechanisms of Functional Loss and Benefits of Exercise

Linda Nici
Respiratory Care June 2024, 69 (6) 640-650; DOI: https://doi.org/10.4187/respcare.11705

REFERENCES

  1. 1.↵
    Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2024.https://goldcopd.org/2024-gold-report.
  2. 2.↵
    1. Divo M,
    2. Celli BR
    . Multimorbidity in patients with chronic obstructive pulmonary disease. Clin Chest Med 2020;41(3):405-419.
    OpenUrl
  3. 3.↵
    1. O’Donnell DE,
    2. James MD,
    3. Milne KM,
    4. Neder JA
    . Dyspnea and exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med 2019;40(2):343-366.
    OpenUrl
  4. 4.↵
    1. Panagiotou M,
    2. Kastanakis E,
    3. Vogiatzis I
    . Exercise limitation in COPD. Pneumon 2013;26(3):245-256.
    OpenUrl
  5. 5.↵
    1. Pepin V,
    2. Saey D,
    3. Laviolette L,
    4. Maltais F
    . Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD 2007;4(3):195-204.
    OpenUrl
  6. 6.↵
    1. Hanania NA,
    2. O’Donnell DE
    . Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstruct Pulmon Dis 2019;14:1127-1138.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Parshall MB,
    2. Schwartzstein RM,
    3. Adams L,
    4. Banzett RB,
    5. Manning HL,
    6. Bourbeau J,
    7. et al
    ; American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185(4):435-452.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Nici L,
    2. Mammen MJ,
    3. Charbek E,
    4. Alexander PE,
    5. Au DH,
    6. Boyd CM,
    7. et al
    . Pharmacologic management of chronic obstructive pulmonary disease. an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med 2020;201(9):e56-e69.
    OpenUrlPubMed
  9. 9.↵
    1. Rochester CL,
    2. Alison JA,
    3. Carlin B,
    4. Jenkins AR,
    5. Cox NR,
    6. Bauldoff G,
    7. et al
    . Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guidelines. Am J Respir Crit Care Med 2023;208(4):e7-e26.
    OpenUrl
  10. 10.↵
    1. Maltais F
    . Exercise and COPD: therapeutic responses, disease-related outcomes, and activity promotion strategies. Phys Sportsmed 2013;41(1):66-80.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Andrianopoulos V,
    2. Klijn P,
    3. Franssen FME,
    4. Spruit MA
    . Exercise training in pulmonary rehabilitation. Clin Chest Med 2014;35(2):313-322.
    OpenUrlPubMed
  12. 12.↵
    1. Souto-Miranda S,
    2. Rodrigues G,
    3. Spruit MA,
    4. Marques A
    . Pulmonary rehabilitation outcomes in individuals with chronic obstructive pulmonary disease: a systematic review. Ann Phys Rehabil Med 2022;65(3):101564.
    OpenUrl
  13. 13.↵
    1. Nyberg A,
    2. Carvalho J,
    3. Bui KL,
    4. Saey D,
    5. Maltais F
    . Adaptations in limb muscle function following pulmonary rehabilitation in patients with COPD- a review. Rev Port Pneumol (2006) 2016;22(6):342-350.
    OpenUrl
  14. 14.↵
    1. De Brandt J,
    2. Spruit MA,
    3. Hansen D,
    4. Franssen FME,
    5. Derave W,
    6. Sillen MJH,
    7. et al
    . Changes in lower-limb muscle function and muscle mass following exercise-based interventions in patients with chronic obstructive pulmonary disease: a review of the English-language literature. Chron Respir Dis 2018;15(2):182-219.
    OpenUrlPubMed
  15. 15.↵
    1. O’Donnell DE,
    2. Revill SM,
    3. Webb KA
    . Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(5):770-777.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. O’Donnell DE
    . Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:180-184.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. O’Donnell DE,
    2. Milne KM,
    3. James MD,
    4. de Torres JP,
    5. Neder JA
    . Dyspnea in COPD: new mechanistic insights and management implications. Adv Ther 2020;37(1):41-60.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Kent BD,
    2. Mitchell PD,
    3. McNicholas WT
    . Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011;6:199-208.
    OpenUrlPubMed
  19. 19.↵
    1. Andrianopoulos V,
    2. Celli BR,
    3. Franssen FME,
    4. Pinto-Plata VM,
    5. Calverley PMA,
    6. Vanfleteren L,
    7. et al
    . Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: results from the ECLIPSE study. Respir Med 2006;119:87-95.
    OpenUrl
  20. 20.↵
    1. Alison JA,
    2. McKeough ZJ,
    3. Leung RWM,
    4. Holland AE,
    5. Hill K,
    6. Morris NR,
    7. et al
    . Oxygen compared to air during exercise training in COPD with exercise-induced desaturation. Eur Respir J 2019;53(5):1802429.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Kawachi S,
    2. Yamamoto S,
    3. Nishie K,
    4. Yamaga T,
    5. Shibuya M,
    6. Sakai Y,
    7. et al
    . The effectiveness of supplemental oxygen during exercise training in patients with chronic obstructive pulmonary disease who show severe exercise-induced desaturation: a protocol for a meta-regression analysis and systematic review. Syst Rev 2021;10(1):110.
    OpenUrl
  22. 22.↵
    1. Pecchiari M,
    2. Pelucchi A,
    3. D’Angelo E,
    4. Foresi A,
    5. Milic-Emili J,
    6. D’Angelo E
    . Effect of heliox breathing on dynamic hyperinflation in COPD patients. Chest 2004;125(6):2075-2082.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Bui KL,
    2. Nyberg A,
    3. Rabinovich R,
    4. Saey D,
    5. Maltais F
    . The relevance of limb muscle dysfunction in chronic obstructive pulmonary disease; a review for clinicians. Clin Chest Med 2019;40(2):367-383.
    OpenUrl
  24. 24.↵
    1. Maltais F,
    2. Decramer M,
    3. Casaburi R,
    4. Barreiro E,
    5. Burelle Y,
    6. Debigare R,
    7. et al
    ; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;189(9):e15-e62.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Barreiro E,
    2. Jaitovich A
    . Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets. J Thorac Dis 2018;10(Suppl 12):S1415-S1424.
    OpenUrl
  26. 26.↵
    1. Remels AHV,
    2. Gosker HR,
    3. Langen RCJ,
    4. Schols AMW
    . The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol (1985) 2013;114(9):1253-1262.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Barreiro E,
    2. Gea J
    . Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease. Chron Respir Dis 2016;13(3):297-311.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Gea J,
    2. Pascual S,
    3. Casadevall C,
    4. Orozco-Levi M,
    5. Barreiro E
    . Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis 2015;7(10):e418-e438.
    OpenUrl
  29. 29.↵
    1. van Bakel SIJ,
    2. Gosker HR,
    3. Langen RC,
    4. Schols AMWJ
    . Towards personalized management of sarcopenia in COPD. Int J Chron Obstruct Pulmon Dis 2021;16(16):25-40.
    OpenUrl
  30. 30.↵
    1. Klimathianaki M,
    2. Vaporidi K,
    3. Georgopoulos D
    . Respiratory muscle dysfunction in COPD: from muscles to cell. Curr Drug Targets 2011;12(4):478-488.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Holland AE
    . Exercise limitation in interstitial lung disease- mechanisms, significance, and therapeutic options. Chron Respir Dis 2010;7(2):101-111.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Wickerson L,
    2. Brooks D,
    3. Mathur S
    . Peripheral muscle dysfunction in interstitial lung disease: a scoping study. Physiother Rehabil 2016;01(03):115.
    OpenUrl
  33. 33.↵
    1. Gille T,
    2. Laveneziana P
    . Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency. Eur Respir Rev 2021;30(162):200355.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Gloeckl R,
    2. Marinov B,
    3. Pitta F
    . Practical recommendations for exercise training in patients with COPD. Eur Respir Rev 2013;22(128):178-186.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Berry MJ,
    2. Sheilds KL,
    3. Adair NE
    . Comparison of effects of endurance and strength training programs in patients with COPD. COPD 2018;15(2):192-199.
    OpenUrl
  36. 36.↵
    1. Spruit MA,
    2. Gosselink R,
    3. Troosters T,
    4. De Paepe K,
    5. Decramer M
    . Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J 2002;19(6):1072-1078.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Sawyer A,
    2. Cavalheri V,
    3. Hill K
    . Effects of high-intensity interval training on exercise capacity in people with chronic pulmonary conditions: a narrative review. BMC Sports Sci Med Rehabil 2020;12:22.
    OpenUrl
  38. 38.↵
    1. Vaes A
    . Partitioning strength exercises as an alternative training modality for patients with COPD. Respirology 2017;22(7):1243-1244.
    OpenUrl
  39. 39.↵
    1. Liao W,
    2. Chen J,
    3. Chen X,
    4. Lin L,
    5. Yan H,
    6. Zhou Y,
    7. et al
    . Impact of resistance training in subjects with COPD: a systematic review and meta-analysis. Respir Care 2015;60(8):1130-1145.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. McKeough ZJ,
    2. Velloso M,
    3. Lima VP,
    4. Alison JA
    . Upper-limb exercises for COPD. Cochrane Database Syst Rev 2016;11(11):CD011434.
    OpenUrl
  41. 41.↵
    1. Figueiredo RIN,
    2. Azambuja AM,
    3. Cureau FV,
    4. Sbruzzi G
    . Inspiratory muscle training in COPD. Respir Care 2020;65(8):1189-1201.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Ammous O,
    2. Feki W,
    3. Lotfi T,
    4. Khamis AM,
    5. Gosselink R,
    6. Rebai A,
    7. et al
    . Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease(COPD). Cochrane Database Syst Rev 2023;1(1):CD013778.
    OpenUrl
  43. 43.↵
    1. Breyer MK,
    2. Breyer-Kohansal R,
    3. Funk GC,
    4. Dornhofer N,
    5. Spruit MA,
    6. Wouters EFM,
    7. et al
    . Nordic walking improves daily physical activities in COPD: a randomized controlled trial. Respir Res 2010;11(1):112.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. McNamara RJ,
    2. McKeough ZJ,
    3. McKenzie DK,
    4. Alison JA
    . Water-based exercise in COPD with physical comorbidities: a randomized controlled trial. Eur Respir J 2013;41(6):1284-1291.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Hong SK,
    2. Cerretelli P,
    3. Cruz JC,
    4. Rahn H
    . Mechanics of respiration during submersion in water. J Appl Physiol 1969;27(4):535-538.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    1. Yang L,
    2. Zhong D,
    3. Zhang Y,
    4. Li Y,
    5. Liu T,
    6. Zheng Y,
    7. et al
    . Tai chi for chronic obstructive pulmonary disease (COPD): an overview of systematic reviews. Int J Gen Med 2021;14:3017-3033.
    OpenUrl
  47. 47.↵
    1. Sahasrabudhe SD,
    2. Orme MW,
    3. Jones AV,
    4. Tillu G,
    5. Sundeep SS,
    6. Singh S
    . Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework. BMJ Open Resp Res 2021;8(1):e000966.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Li C,
    2. Liu Y,
    3. Ji Y,
    4. Xie L,
    5. Hou Z
    . Efficacy of yoga training in chronic obstructive pulmonary disease patients: a systematic review and meta-analysis. Complement Ther Clin Pract 2018;30:33-37.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Jacobs SS,
    2. Krishnan JA,
    3. Lederer DJ,
    4. Ghazipura M,
    5. Hossain T,
    6. Tan AYM,
    7. et al
    . Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med 2020;202(10):e121-e141.
    OpenUrlPubMed
  50. 50.↵
    1. Xiang G,
    2. Wu Q,
    3. Wu X,
    4. Hao S,
    5. Xie L,
    6. Li S
    . Noninvasive ventilation intervention during exercise training in individuals with chronic obstructive pulmonary disease: a systemic review and meta-analysis. Ann Phys Rehabil Med 2021;64(6):101460.
    OpenUrl
  51. 51.↵
    1. Mayer AF,
    2. Karloh M,
    3. dos Santos K,
    4. Pereira de Araujo CL,
    5. Gulart AA
    . Effects of acute use of pursed-lips breathing during exercise in patients with COPD: a systematic review and meta-analysis. Physiotherapy 2018;104(1):9-17.
    OpenUrl
  52. 52.↵
    1. Hill K,
    2. Cavalheri V,
    3. Mathur S,
    4. Roig M,
    5. Janaudis-Ferreira T,
    6. Robles P,
    7. et al
    . Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2018;5(5):CD010821.
    OpenUrl
  53. 53.↵
    1. Warburton DER,
    2. Nicol CW,
    3. Bredin SSD
    . Health benefits of physical activity: the evidence. CMAJ 2006;174(6):801-809.
    OpenUrlAbstract/FREE Full Text
  54. 54.↵
    1. Koreny M,
    2. Demeyer H,
    3. Benet M,
    4. Arbillaga-Etxarri A,
    5. Balcells E,
    6. Barberan-Garcia A,
    7. et al
    ; PROactive Consortium members. Patterns of physical activity progression in patients with COPD. Arch Bronconeumol (Engl Ed) 2021;57(3):214-223.
    OpenUrl
  55. 55.↵
    1. van Lummel RC,
    2. Walgaard S,
    3. Pijnappels M,
    4. Elders PJ,
    5. Garcia-Aymerich J,
    6. van Dieën JH,
    7. et al
    . Physical performance and physical activity in older adults: associated but separate domains of physical function in old age. PLoS One 2015;10(12):e0144048.
    OpenUrl
  56. 56.↵
    1. Osadnik CR,
    2. Loeckx M,
    3. Louvaris Z,
    4. Demeyer H,
    5. Langer D,
    6. Rodrigues FM,
    7. et al
    . The likelihood of improving physical activity after pulmonary rehabilitation is increased in patients with COPD who have better exercise tolerance. Int J Chron Obstruct Pulmon Dis 2018;13:3515-3527.
    OpenUrl
  57. 57.↵
    1. Troosters T,
    2. Maltais F,
    3. Leidy N,
    4. Lavoie K,
    5. Sedeno M,
    6. Janssens W,
    7. et al
    . Effect of bronchodilation, exercise training, and behavior modification on symptoms and physical activity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2018;198(8):1021-1032.
    OpenUrlPubMed
  58. 58.↵
    1. Blondeel A,
    2. Demeyer H,
    3. Janssens W,
    4. Troosters T
    . The role of physical activity in the context of pulmonary rehabilitation. COPD 2018;15(6):632-639.
    OpenUrlPubMed
  59. 59.↵
    1. Koolen EH,
    2. van Hees HW,
    3. van Lummel RC,
    4. Dekhuijzen R,
    5. Djamin RS,
    6. Spruit MA,
    7. et al
    . “Can do” versus “do do”: a novel concept to better understand physical functioning in patients with chronic obstructive pulmonary disease. J Clin Med 2019;8(3):340.
    OpenUrl
  60. 60.↵
    1. Singh S
    . Physical activity and pulmonary rehabilitation- a competing agenda? Chron Respir Dis 2014;11(4):187-189.
    OpenUrlCrossRefPubMed
  61. 61.
    1. O’Donnell DE,
    2. Banzett RB,
    3. Carrieri-Kohlman V,
    4. Casaburi R,
    5. Davenport PW,
    6. Gandevia SC,
    7. et al
    . Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007;4(2):145-168.
    OpenUrlCrossRefPubMed
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords